 SAINT LAURENT, Quebec, Sept. 07, 2021 GLOBE NEWSWIRE -- IntelGenx Corp. TSX V:IGXOTCQB:IGXT the Company or IntelGenx today announced that Exeltis Healthcare S.L. Exeltis, its commercialization partner in the European Union EU for RIZAPORT, a unique for the treatment of acute migraines, has launched the product in Spain. 